Compare · EW vs WBX
EW vs WBX
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Wallbox N.V. (WBX): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while WBX operates in Consumer Discretionary - the two are in different parts of the market.
- EW is the larger of the two at $48.42B, about 914.9x WBX ($52.9M).
- WBX has been more active in the news (10 items in the past 4 weeks vs 6 for EW).
- EW has more recent analyst coverage (25 ratings vs 14 for WBX).
- Company
- Edwards Lifesciences Corporation
- Wallbox N.V.
- Price
- -
- -
- Market cap
- $48.42B
- $52.9M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 6
- 10
- Recent ratings
- 25
- 14
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Wallbox N.V.
Wallbox N.V., a technology company, creates electric vehicle charging and energy management systems that redefine users' relationship to the grid. It provides a portfolio of charging and energy management solutions for residential, semi-public, and public use worldwide. The company was founded in 2015 and is based in Barcelona, Spain.
Latest EW
- Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference
- Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
- SEC Form 4 filed by Ullem Scott B.
- SEC Form 4 filed by Lippis Daniel J.
- SEC Form 4 filed by Bobo Donald E Jr
- Edwards Lifesciences upgraded by Wolfe Research with a new price target
- Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
- Amendment: SEC Form SCHEDULE 13G/A filed by Edwards Lifesciences Corporation
Latest WBX
- SEC Form 6-K filed by Wallbox N.V.
- New International Banks Join Wallbox's Financial Restructuring Plan
- SEC Form 6-K filed by Wallbox N.V.
- Amendment: SEC Form SCHEDULE 13D/A filed by Wallbox N.V.
- Wallbox Announces Timing of its First Quarter 2026 Financial Results
- Wallbox Announces Filing of 2025 Annual Report on Form 20-F
- SEC Form 20-F filed by Wallbox N.V.
- SEC Form 3 filed by new insider Ordonez Beatriz Gonzalez
- Wallbox Signs Comprehensive Restructuring Plan and Secures €11 Million in Interim Financing
- SEC Form 6-K filed by Wallbox N.V.